Bruno Anthony D
Insider CIK 1374180 · WCRX Exec. V.P., Corp. Development · MNLO Director · FOMX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2024-12-12 | 2024-12-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2024-01-01 | 2024-01-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2023-12-13 | 2023-12-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2022-08-10 | 2022-08-12 | 20,500 | — | $0 | 20,500 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2021-07-19 | 2021-07-20 | 20,500 | — | $0 | 20,500 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-08-03 | 2020-08-05 | 22,500 | — | $0 | 22,500 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-04-03 | 2020-04-07 | 75,690 | — | $0 | 120,123 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-04-03 | 2020-04-07 | 14,933 | — | $0 | 135,056 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-19 | 2020-03-23 | 45,000 | — | $0 | 45,000 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 62,647 | — | $0 | 12,360 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 12,360 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 7,321 | — | $0 | 44,433 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 37,112 | — | $0 | 37,112 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2020-02-27 | 2020-03-03 | 5,312 | — | $0 | 75,007 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2019-05-16 | 2019-05-20 | 28,195 | — | $0 | 69,695 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer | 2011-12-31 | 2012-01-03 | 61,512 | — | $0 | 246,611 | SEC↗ |